Overview
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 3 of 3 financial statements were filed late (the longest delay 1017 days for 2022).
- 2025not filed
- 202429/04/2026
- 202327/04/2026
- 202227/04/2026
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2024.
Results vs industry
Industry
Website technology
- Analytics and marketing
- Google Analytics
Authorized Representatives
Manner of representation
If the management board consists of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.
Ownership
| Owner | Share value | Stake |
|---|---|---|
| $53,754.73 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2022-11-16.
79 2490 0005 0000 4530 4979 8072- 89 2490 1057 0000 9902 1237 6523
- 98 2490 1057 0000 9900 1237 6523
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| GenxoneS.A. | $665,361.35 | genxone.eu | ||
| Polbiotech Laboratoriumsp. z o.o. | $645,943.81 | polbiotech.pl | ||
| Relvosp. z o.o. | $120,693.26 | relvo.pl | ||
| Microblicsp. z o.o. | $122,383.50 | microblic.pl | ||
| Microbe Plussp. z o.o. | $104,197.26 | microbe-plus.com | ||
| WPD Pharmaceuticalssp. z o.o. | $90,822.78 | wpdpharmaceuticals.com | ||
| Xenstatssp. z o.o. | $66,774.27 | xenstats.com | ||
| Fungotechsp. z o.o. | $187.68 | fungo.tech | ||
| Dystrogen TherapeuticsS.A. | – | dystrogen.com | ||
| MIMO BiotechP.S.A. | – | mimobiotech.com |
FAQ
Last updated: 2026-06-03